{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:52:10Z","timestamp":1791989530479,"version":"4.4.0"},"reference-count":27,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Malignant peripheral nerve sheath tumors (MPNSTs) are an aggressive group of soft tissue sarcomas that can arise sporadically, in the context of neurofibromatosis Type 1 (NF1) or at a site of prior irradiation. Large series profiling the features and outcomes of sporadic, NF1-associated, and radiation-associated MPNSTs are limited. The goal of this study was to elucidate differences between MPNST etiologies in a large single-institution retrospective study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Patients (n = 317) were identified through the tumor registry of The University of Texas MD Anderson Cancer Center. Clinicopathological features were retrospectively collected. Features were compared among MPNST subtypes for patients who had sufficient clinical history (n = 289), and clinicopathological features were used to identify adverse predictors of recurrence and survival outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Five-year local recurrence-free survival (LRFS), distant recurrence-free survival (DRFS), and disease-specific survival (DSS) estimates were 56.6%, 49.6%, and 53.6%, respectively, for the high-grade MPNST cohort. Five-year DSS was lower in NF1-associated and radiation-associated MPNST than in sporadic MPNST (52%, 47%, and 67%, respectively, p = 0.140). Patients with radiation-associated MPNST had worse 5-year LRFS than those with the sporadic and NF1-associated subtypes (RT-associated vs sporadic, p = 0.010; RT-associated vs NF1-associated, p = 0.232). Truncally located tumors, positive surgical margins, local recurrence, and metastasis were predictors of adverse DSS in multivariate analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Radiation-associated MPNSTs are associated with poorer local recurrence-free and disease-specific survival than sporadic and NF1-associated tumors. NF1-associated MPNSTs may have worse survival outcomes owing to large tumor size, compromising truncal location, and lower rate of negative resection margins compared with sporadic tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2015.12.jns152443","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T10:08:55Z","timestamp":1459505335000},"page":"319-329","source":"Crossref","is-referenced-by-count":131,"title":["Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1\u2013associated, and radiation-associated malignant peripheral nerve sheath tumors"],"prefix":"10.3171","volume":"126","author":[{"given":"Kelsey L.","family":"Watson","sequence":"first","affiliation":[{"name":"Departments of Surgical Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadah A.","family":"Al Sannaa","sequence":"additional","affiliation":[{"name":"Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Kivlin","sequence":"additional","affiliation":[{"name":"Departments of Surgical Oncology,"},{"name":"The University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis R.","family":"Ingram","sequence":"additional","affiliation":[{"name":"Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M.","family":"Landers","sequence":"additional","affiliation":[{"name":"Departments of Surgical Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"Roland","sequence":"additional","affiliation":[{"name":"Departments of Surgical Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice N.","family":"Cormier","sequence":"additional","affiliation":[{"name":"Departments of Surgical Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly K.","family":"Hunt","sequence":"additional","affiliation":[{"name":"Departments of Surgical Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry W.","family":"Feig","sequence":"additional","affiliation":[{"name":"Departments of Surgical Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Ashleigh Guadagnolo","sequence":"additional","affiliation":[{"name":"Radiation Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Bishop","sequence":"additional","affiliation":[{"name":"Radiation Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lien","family":"Wang","sequence":"additional","affiliation":[{"name":"Pathology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Slopis","sequence":"additional","affiliation":[{"name":"Neuro-Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian E.","family":"McCutcheon","sequence":"additional","affiliation":[{"name":"Neurosurgery, The University of Texas MD Anderson Cancer Center; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandar J.","family":"Lazar","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keila E.","family":"Torres","sequence":"additional","affiliation":[{"name":"Departments of Surgical Oncology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns152443","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/cncr.22098","article-title":"Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution","volume":"107","author":"Anghileri M,","year":"2006","unstructured":"Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, : Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer 107:1065\u20131074, 200610.1002\/cncr.22098"},{"key":"b2-jns152443","series-title":"J Surg Oncol","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/jso.23736","article-title":"The effect of surgical margins on outcomes for low grade MPNSTs and atypical neurofibroma","volume":"110","author":"Bernthal NM,","year":"2014","unstructured":"Bernthal NM, Putnam A, Jones KB, Viskochil D, Randall RL: The effect of surgical margins on outcomes for low grade MPNSTs and atypical neurofibroma. J Surg Oncol 110:813\u2013816, 201410.1002\/jso.2373625111615"},{"key":"b3-jns152443","series-title":"Curr Treat Options Oncol","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11864-015-0328-6","article-title":"Current treatment options for malignant peripheral nerve sheath tumors","volume":"16","author":"Bradford D,","year":"2015","unstructured":"Bradford D, Kim A: Current treatment options for malignant peripheral nerve sheath tumors. Curr Treat Options Oncol 16:328, 201510.1007\/s11864-015-0328-625777573"},{"key":"b4-jns152443","series-title":"Ann Surg","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/SLA.0000000000000869","article-title":"Lessons learned from the study of 10,000 patients with soft tissue sarcoma","volume":"260","author":"Brennan MF,","year":"2014","unstructured":"Brennan MF, Antonescu CR, Moraco N, Singer S: Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg 260:416\u2013422, 201410.1097\/SLA.0000000000000869"},{"key":"b5-jns152443","series-title":"J Nucl Med","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2967\/jnumed.114.142372","article-title":"18F-FDG PET\/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization","volume":"56","author":"Chirindel A,","year":"2015","unstructured":"Chirindel A, Chaudhry M, Blakeley JO, Wahl R: 18F-FDG PET\/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization. J Nucl Med 56:379\u2013385, 201510.2967\/jnumed.114.14237225655626"},{"key":"b6-jns152443","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","article-title":"Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases","volume":"57","author":"Ducatman BS,","year":"1986","unstructured":"Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM: Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 57:2006\u20132021, 198610.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-63082508"},{"key":"b7-jns152443","series-title":"Clin Transl Oncol","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12094-013-1061-x","article-title":"Clinical and molecular prognostic predictors of malignant peripheral nerve sheath tumor","volume":"16","author":"Fan Q,","year":"2014","unstructured":"Fan Q, Yang J, Wang G: Clinical and molecular prognostic predictors of malignant peripheral nerve sheath tumor. Clin Transl Oncol 16:191\u2013199, 201410.1007\/s12094-013-1061-x23749326"},{"key":"b8-jns152443","series-title":"Oncologist","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1634\/theoncologist.2013-0328","article-title":"Malignant peripheral nerve sheath tumors","volume":"19","author":"Farid M,","year":"2014","unstructured":"Farid M, Demicco EG, Garcia R, Ahn L, Merola PR, Cioffi A, : Malignant peripheral nerve sheath tumors. Oncologist 19:193\u2013201, 20142447053110.1634\/theoncologist.2013-0328"},{"key":"b9-jns152443","series-title":"WHO Classification of Tumours of Soft Tissue and Bone","year":"2013","unstructured":"Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F: WHO Classification of Tumours of Soft Tissue and Bone Lyon, France, IARC, 2013"},{"key":"b10-jns152443","series-title":"J Clin Oncol","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1200\/JCO.2009.25.1728","article-title":"Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas?","volume":"28","author":"Gladdy RA,","year":"2010","unstructured":"Gladdy RA, Qin LX, Moraco N, Edgar MA, Antonescu CR, Alektiar KM, : Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas?. J Clin Oncol 28:2064\u20132069, 201010.1200\/JCO.2009.25.172820308666"},{"key":"b11-jns152443","series-title":"J Surg Oncol","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/jso.20971","article-title":"Malignant peripheral nerve sheath tumor: molecular pathogenesis and current management considerations","volume":"97","author":"Grobmyer SR,","year":"2008","unstructured":"Grobmyer SR, Reith JD, Shahlaee A, Bush CH, Hochwald SN: Malignant peripheral nerve sheath tumor: molecular pathogenesis and current management considerations. J Surg Oncol 97:340\u2013349, 20081828646610.1002\/jso.20971"},{"key":"b12-jns152443","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0165-4608(94)90081-7","article-title":"Cytogenetic analysis of soft tissue sarcomas. Recurrent chromosome abnormalities in malignant peripheral nerve sheath tumors (MPNST)","volume":"78","author":"Jhanwar SC,","year":"1994","unstructured":"Jhanwar SC, Chen Q, Li FP, Brennan MF, Woodruff JM: Cytogenetic analysis of soft tissue sarcomas. Recurrent chromosome abnormalities in malignant peripheral nerve sheath tumors (MPNST). Cancer Genet Cytogenet 78:138\u2013144, 1994782814410.1016\/0165-4608(94)90081-7"},{"key":"b13-jns152443","series-title":"Mol Cancer Ther","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1158\/1535-7163.MCT-07-2335","article-title":"Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors","volume":"7","author":"Johansson G,","year":"2008","unstructured":"Johansson G, Mahller YY, Collins MH, Kim MO, Nobukuni T, Perentesis J, : Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. Mol Cancer Ther 7:1237\u20131245, 200810.1158\/1535-7163.MCT-07-233518483311"},{"key":"b14-jns152443","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/neuonc\/nos287","article-title":"Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1","volume":"15","author":"Kolberg M,","year":"2013","unstructured":"Kolberg M, H\u00f8land M, Agesen TH, Brekke HR, Liest\u00f8l K, Hall KS, : Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1. Neuro Oncol 15:135\u2013147, 20132316177410.1093\/neuonc\/nos287"},{"key":"b15-jns152443","series-title":"Ann Surg Oncol","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1245\/s10434-012-2573-2","article-title":"Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors","volume":"20","author":"LaFemina J,","year":"2013","unstructured":"LaFemina J, Qin LX, Moraco NH, Antonescu CR, Fields RC, Crago AM, : Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors. Ann Surg Oncol 20:66\u201372, 20132287861810.1245\/s10434-012-2573-2"},{"key":"b16-jns152443","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1158\/0008-5472.CAN-10-2799","article-title":"Autophagic survival in resistance to histone deacetylase inhibitors: novel strategies to treat malignant peripheral nerve sheath tumors","volume":"71","author":"Lopez G,","year":"2011","unstructured":"Lopez G, Torres K, Liu J, Hernandez B, Young E, Belousov R, : Autophagic survival in resistance to histone deacetylase inhibitors: novel strategies to treat malignant peripheral nerve sheath tumors. Cancer Res 71:185\u2013196, 20112108427610.1158\/0008-5472.CAN-10-2799"},{"key":"b17-jns152443","series-title":"J Pathol","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/(SICI)1096-9896(200001)190:1<31::AID-PATH505>3.0.CO;2-#","article-title":"Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group","volume":"190","author":"Mertens F,","year":"2000","unstructured":"Mertens F, Dal Cin P, De Wever I, Fletcher CDM, Mandahl N, Mitelman F, : Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. J Pathol 190:31\u201338, 200010.1002\/(SICI)1096-9896(200001)190:1<31::AID-PATH505>3.0.CO;2-#"},{"key":"b18-jns152443","series-title":"Natl Inst Health Consens Dev Conf Consens Statement","first-page":"1","article-title":"Neurofibromatosis","volume":"6:","year":"1987","unstructured":"Neurofibromatosis. Natl Inst Health Consens Dev Conf Consens Statement 6::1\u20137, 1987"},{"key":"b19-jns152443","series-title":"Sarcoma","doi-asserted-by":"publisher","first-page":"756395","DOI":"10.1155\/2009\/756395","article-title":"Survival in malignant peripheral nerve sheath tumours: a comparison between sporadic and neurofibromatosis Type 1-associated tumours","volume":"2009","author":"Porter DE,","year":"2009","unstructured":"Porter DE, Prasad V, Foster L, Dall GF, Birch R, Grimer RJ: Survival in malignant peripheral nerve sheath tumours: a comparison between sporadic and neurofibromatosis Type 1-associated tumours. Sarcoma 2009:756395, 20091936011510.1155\/2009\/756395"},{"key":"b20-jns152443","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/ng.2641","article-title":"Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis","volume":"45","author":"Rahrmann EP,","year":"2013","unstructured":"Rahrmann EP, Watson AL, Keng VW, Choi K, Moriarity BS, Beckmann DA, : Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nat Genet 45:756\u2013766, 201310.1038\/ng.264123685747"},{"key":"b21-jns152443","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00401-012-0954-z","article-title":"Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems","volume":"123","author":"Rodriguez FJ,","year":"2012","unstructured":"Rodriguez FJ, Folpe AL, Giannini C, Perry A: Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol 123:295\u2013319, 20122232736310.1007\/s00401-012-0954-z"},{"key":"b22-jns152443","series-title":"Am J Surg Pathol","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1097\/PAS.0000000000000447","article-title":"Malignant peripheral nerve sheath tumor (MPNST) arising in diffuse-type neurofibroma: clinicopathologic characterization in a series of 9 cases","volume":"39","author":"Schaefer IM,","year":"2015","unstructured":"Schaefer IM, Fletcher CD: Malignant peripheral nerve sheath tumor (MPNST) arising in diffuse-type neurofibroma: clinicopathologic characterization in a series of 9 cases. Am J Surg Pathol 39:1234\u20131241, 201510.1097\/PAS.0000000000000447"},{"key":"b23-jns152443","series-title":"Ann Surg Oncol","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1245\/s10434-011-1978-7","article-title":"Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience","volume":"19","author":"Stucky CC,","year":"2012","unstructured":"Stucky CC, Johnson KN, Gray RJ, Pockaj BA, Ocal IT, Rose PS, : Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol 19:878\u2013885, 201210.1245\/s10434-011-1978-7"},{"key":"b24-jns152443","series-title":"Enzinger and Weiss's Soft Tissue Tumors","first-page":"903","article-title":"Malignant tumors of the peripheral nerves","author":"Weiss SW,","year":"2008","unstructured":"Weiss SW, Goldblum JR: Malignant tumors of the peripheral nerves. Enzinger and Weiss's Soft Tissue Tumors ed 5St Louis, Mosby Elsevier, 2008. 903\u2013925"},{"key":"b25-jns152443","series-title":"Ann Surg","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1097\/SLA.0b013e3181a77e9a","article-title":"Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome","volume":"249","author":"Zou C,","year":"2009","unstructured":"Zou C, Smith KD, Liu J, Lahat G, Myers S, Wang WL, : Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg 249:1014\u20131022, 200910.1097\/SLA.0b013e3181a77e9a19474676"},{"key":"b26-jns152443","series-title":"Mol Cancer Ther","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1158\/1535-7163.MCT-08-1008","article-title":"Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor","volume":"8","author":"Zou CY,","year":"2009","unstructured":"Zou CY, Smith KD, Zhu QS, Liu J, McCutcheon IE, Slopis JM, : Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor. Mol Cancer Ther 8:1157\u20131168, 200910.1158\/1535-7163.MCT-08-100819417153"},{"key":"b27-jns152443","series-title":"Eur J Nucl Med Mol Imaging","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1007\/s00259-014-2756-0","article-title":"The value of 18F-FDG PET\/CT in the management of malignant peripheral nerve sheath tumors","volume":"41","author":"Khiewvan B,","year":"2014","unstructured":"Khiewvan B, Macapinlac HA, Lev D, McCutcheon IE, Slopis JM, Al Sannaa G, : The value of 18F-FDG PET\/CT in the management of malignant peripheral nerve sheath tumors. Eur J Nucl Med Mol Imaging 41:1756\u20131766, 201410.1007\/s00259-014-2756-024699907"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/126\/1\/article-p319.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/126\/1\/article-p319.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/126\/1\/article-p319.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T23:16:13Z","timestamp":1742685373000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/126\/1\/article-p319.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":27,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/2015.12.jns152443","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}